Continuous venovenous hemofiltration improves cardiac performance by mechanisms other than tumor necrosis factor-α attenuation during endotoxic shock

Critical Care Medicine

Volumn 27, Issue 9, 1999, Pages 1848-1855

  Rogiers, Peter ^a   Zhang, Haibo ^b   Smail, Nadia ^b   Pauwels, Dirk ^a   Vincent, Jean Louis ^b  

^a MIDDELHEIM HOSPITAL   (Belgium)

^b ERASME HOSPITAL   (Belgium)

Author keywords

Arterial pressure; Blood flow; Cytokines; Hemodynamics; Hemofiltration; Immunotherapy; Inflammatory mediators; Myocardial depression; Septic shock

Indexed keywords

LACTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOG; FEMALE; HEART HEMODYNAMICS; HEMOFILTRATION; INFLAMMATION; LACTATE BLOOD LEVEL; LUNG VASOCONSTRICTION; MALE; NONHUMAN; PRIORITY JOURNAL; SEPTIC SHOCK;

ANALYSIS OF VARIANCE; ANIMALS; CARDIOMYOPATHIES; DOGS; HEMODYNAMIC PROCESSES; HEMOFILTRATION; IMMUNOTHERAPY; INFLAMMATION MEDIATORS; LACTIC ACID; REGIONAL BLOOD FLOW; SHOCK, SEPTIC; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032829843     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-199909000-00024     Document Type: Article

References (33)

1. 1. Parrillo JE: Pathogenetic mechanisms of septic shock. N Engl J Med 1993; 328:1471-1477
2. 2. Damas P, Reuter A, Gysen P, et al: Tumor necrosis factor and interleukin-1 serum levels during severe sepsis in humans. Crit Care Med 1989; 17:975-979
3. 3. Pinsky MR, Vincent J-L, Deviere J, et al: Serum cytokine levels in human septic shock. Chest 1993; 103:565-575
4. 4. Hoffman WD, Natanson C: The role of endotoxin in bacterial septic shock. In: Yearbook of Intensive Care and Emergency Medicine 1993. Vincent JL (Ed). Berlin, Springer-Verlag, 1993, pp 49-63
5. 5. Natanson C, Hoffman WD, Suffredini AF, et al: Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 1994; 120: 771-783
6. 6. Bellomo R: Continuous hemofiltration as blood purification in sepsis. New Horiz 1995; 3:732-737
7. 7. Stein B, Pfenninger E, Grunert A, et al: Influence of continuous hemofiltration on hemodynamics and central blood volume in experimental endotoxic shock. Intensive Care Med 1990; 16:494-499
8. 8. Freeman BD, Yatsiv I, Natanson C, et al: Continuous arteriovenous hemofiltration does not improve survival in a canine model of septic shock. J Am Coll Surg 1995; 180: 286-292
9. 9. Lee PA, Matson JR, Pryor RW, et al: Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus induced septicemia in immature swine. Crit Care Med 1993; 21:914-924
10. 10. Grootendorst AF, van Bommel EFH, van der Hoven B, et al: High-volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992; 7:67-75
11. 11. Grootendorst AF, van Bommel EFH, van der Hoven B, et al: High volume hemofiltration improves right ventricular function of endotoxin induced shock in the pig. Intensive Care Med 1992; 18:235-240
12. 12. Grootendorst AF, van Bommel EFH, van Leengoed LAMG, et al: High volume hemofiltration improves hemodynamics and survival of pigs exposed to gut ischemia and reperfusion. Shock 1994; 1:1-8
13. 13. Zhang H, Rogiers P, Preiser J-C, et al: Effects of methylene blue on oxygen availability and regional blood flow during endotoxic shock. Crit Care Med 1995; 23:1711-1721
14. 14. Zhang H, Spapen H, Manikis P, et al: Tirilazad mesylate (U74006F) inhibits the effects of endotoxin in dogs. Am J Physiol 1995; 268:H1847-H1855
15. 15. Staubach KH, Rau HG, Kooistra HM, et al: Can hemofiltration increase survival time in acute endotoxemia? A porcine shock model. Prog Clin Biol Res 1989; 308:821-826
16. 16. Gomez A, Wang R, Unruh H, et al: Hemofiltration reverses left ventricular dysfunction during sepsis in dogs. Anesthesiology 1990; 73:671-685
17. 17. Mink SN, Jha P, Wang R, et al: Effects of continuous arteriovenous hemofiltration with systemic vasopressor therapy on depressed left ventricular contractility and tissue oxygen delivery in canine Escherichia coli sepsis. Anesthesiology 1995; 83:178-190
18. 18. Grootendorst AF, van Bommel EFH, van der Hoven B, et al: Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs. J Crit Care 1993; 8:161-169
19. 19. Heard SO, Perkins MW, Fink MP: Tumor necrosis factor alpha causes myocardial depression in guinea pigs. Crit Care Med 1992; 20:523-527
20. 20. Bellomo R, Tipping P, Boyce N: Continuous venovenous hemofiltration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993; 21:522-526
21. 21. Tonnesen E, Hansen MB, Höhndorf K, et al: Cytokines in plasma and ultrafiltrate during continuous arteriovenous hemofiltration. Anaesth Intensive Care 1993; 21:752-758
22. 22. van Bommel EFH, Hesse CJ, Jutte NHPM, et al: Cytokine kinetics (TNF-alpha, IL-1beta, IL-6) during continuous hemofiltration: A laboratory and clinical study. Contrib Nephrol 1995; 116:62-75
23. 23. Heidemann SM, Ofenstein JP, Sarnaik AP: Efficacy of continuous arteriovenous hemofiltration in endotoxic shock. Circ Shock 1994; 44:183-187
24. 24. Bottoms G, Fessler J, Murphey E, et al: Efficacy of convective removal of plasma mediators of endotoxic shock by continuous venovenous hemofiltration. Shock 1996; 5:149-154
25. 25. Goldfarb S, Golper T: Proinflammatory cytokines and hemofiltration membranes. J Am Soc Nephrol 1994; 5:228-232
26. 26. van Bommel EF, Hesse CJ, Jutte NH, et al: Impact of continuous hemofiltration on cytokines and cytokine inhibitors in oliguric patients suffering from systemic inflammatory response syndrome. Renal Failure 1997; 19:443-454
27. 27. Bellomo R, Tipping P, Boyce N: Interleukin-6 and interleukin-8 extraction during continuous venovenous hemodiafiltration in septic acute renal failure. Renal Failure 1995; 17: 457-466
28. 28. Elliott D, Wiles C, Reynolds H: Removal of cytokines in septic patients using continuous venovenous hemodiafiltration. Letter. Crit Care Med 1994; 22:718-719
29. 29. Ronco C, Tetta C, Motellon JL, et al: Removal of septic mediators in experimental continuous high volume hemofiltration. Abstr. J Am Soc Nephrol 1995; 6:500
30. 30. Malchesky PS, Zborowski M, Hou KC: Extracorporeal techniques of endotoxin removal: A review of the art and science. Adv Renal Replacement Ther 1995; 2:60-69
31. 31. Kierdorf H, Leue C, Heintz B, et al: Continuous venovenous hemofiltration in acute renal failure: Is a bicarbonate-or lactate-buffered substitution better? Contrib Nephrol 1995; 116:38-47
32. 32. Marangoni R, Civardi F, Masi F, et al: Lactate versus bicarbonate on-line hemofiltration: A comparative study. Artif Organs 1995; 19: 490-495
33. 33. Böhm R, Gladziwa U, Clasen W, et al: Which bicarbonate concentration is adequate to lactate-buffered substitution fluids in maintenance hemofiltration? Clin Nephrol 1994; 42: 257-262